HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 UVEITIS

被引:47
作者
MOCHIZUKI, M
TAJIMA, K
WATANABE, T
YAMAGUCHI, K
机构
[1] AICHI CANC CTR, RES INST, DIV EPIDEMIOL, CHIKUSA KU, NAGOYA, AICHI 464, JAPAN
[2] UNIV TOKYO, INST MED SCI, DEPT PATHOL, MINATO KU, TOKYO, TOKYO 108, JAPAN
[3] KUMAMOTO UNIV, SCH MED, DEPT INTERNAL MED, HONJO, KUMAMOTO 860, JAPAN
关键词
D O I
10.1136/bjo.78.2.149
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The human retroviruses, HTLV-I and HIV, are playing clinically important roles in a variety of ocular disorders, particularly in uveitis. Both viruses are integrated in the genome of infected T cells. HIV-I infection causes the death of the infected T cells, thereby affecting the host defence system and causing AIDS. Subsequent opportunistic infections of ocular tissues, such as CMV retinitis, are a serious problem in clinical ophthalmology all over the world. Another human retrovirus, HTLV-I, has been known as the causative agent of T cell malignancies (ATL and T cell lymphoma) and chronic myelopathy (HAM/TSP), and is now recognised as a causative agent for a specific type of intraocular inflammation characterised by vitreous opacities with mild iritis and mild retinal vasculitis (HTLV-I uveitis). The mechanism by which HTLV-I causes uveitis is still unknown, but our recent data suggest that it is most probably an immune mediated mechanism by activated CD4 T cells infected with the virus. HTLV-I uveitis, therefore, may implicate a significant role of retroviruses in autoimmune diseases and further the pathogenesis of diseases with infection/autoimmune overlap.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 50 条
  • [41] Human T-lymphotropic virus type 1 infection and solid organ transplantation
    Taylor, Graham P.
    REVIEWS IN MEDICAL VIROLOGY, 2018, 28 (02)
  • [42] Defective human T-lymphotropic virus Type 1 provirus in asymptomatic carriers
    Takenouchi, Hiroyuki
    Umeki, Kazumi
    Sasaki, Daisuke
    Yamamoto, Ikuo
    Nomura, Hajime
    Takajo, Ichiro
    Ueno, Shiro
    Umekita, Kunihiko
    Kamihira, Shimeru
    Morishita, Kazuhiro
    Okayama, Akihiko
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (06) : 1335 - 1343
  • [43] Checkpoints modulation by the Human T-lymphotropic virus type 1 Tax protein
    Alexandre Carpentier
    Pierre-Yves Barez
    Mathieu Boxus
    Luc Willems
    Retrovirology, 11 (Suppl 1)
  • [44] Association between onychodystrophy and human T-lymphotropic virus type 1 infection
    Mayer, Erick F.
    Ita, Fanny
    Gonzalez, Elsa
    Verdonck, Kristien
    Bravo, Francisco
    Clark, Daniel
    Gotuzzo, Eduardo
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (05) : E312 - E316
  • [45] Human T-Lymphotropic Virus type 1 infective dermatitis in central Australia
    Einsiedel, Lloyd
    Cassar, Olivier
    Gordon, Lynne
    Gessain, Antoine
    JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (04) : 370 - 373
  • [46] Human T-lymphotropic virus 1 neurologic disease
    Araujo, Abelardo
    Lima, Marco Antonio
    Silva, Marcus Tulius T.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2008, 10 (03) : 193 - 200
  • [48] Rhabdomyolysis Due to Myopathy From Human T-Lymphotropic Virus Type 1
    Brewer, Michael
    Evans, James
    Bhagat, Rajesh
    Herrin, Vince
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [49] Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1
    Silva, Marcus T. T.
    Neves, Elizabeth S.
    Grinsztejn, Beatriz
    Espindola, Otavio de Melo
    Schor, Doris
    Araujo, Abelardo
    AIDS, 2012, 26 (04) : 521 - 523
  • [50] Molecular targeting for treatment of human T-lymphotropic virus type 1 infection
    Soltani, Arash
    Hashemy, Seyed Isaac
    Avval, Farnaz Zahedi
    Soleimani, Anvar
    Rafatpanah, Houshang
    Rezaee, Seyed Abdorahim
    Griffith, Renate
    Mashkani, Baratali
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 770 - 778